
CBD and CBG Reprogram Liver Energy to Reverse Fatty Liver in Mice
Israeli researchers found that non-psychoactive cannabis compounds CBD and CBG can reverse liver damage in obese mice with MASLD by reprogramming liver energy use, boosting phosphocreatine reserves and lysosomal activity, and improving insulin resistance and lipid profiles. The treated mice showed reduced fat accumulation and inflammation without dietary changes, suggesting a new metabolic pathway to target in MASLD. However, these results are preclinical, and human relevance requires careful dosing considerations and clinical trials, as consumer CBD/CBG products vary in purity and concentration.



